Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Long-Term Deferred Tax (2016 - 2022)

Historic Long-Term Deferred Tax for Orthofix Medical (OFIX) over the last 13 years, with Q3 2022 value amounting to $1.5 million.

  • Orthofix Medical's Long-Term Deferred Tax fell 9321.17% to $1.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.5 million, marking a year-over-year decrease of 9321.17%. This contributed to the annual value of $1.8 million for FY2021, which is 9292.79% down from last year.
  • According to the latest figures from Q3 2022, Orthofix Medical's Long-Term Deferred Tax is $1.5 million, which was down 9321.17% from $1.5 million recorded in Q2 2022.
  • In the past 5 years, Orthofix Medical's Long-Term Deferred Tax registered a high of $39.6 million during Q3 2019, and its lowest value of $1.5 million during Q2 2022.
  • Moreover, its 5-year median value for Long-Term Deferred Tax was $30.6 million (2018), whereas its average is $25.8 million.
  • In the last 5 years, Orthofix Medical's Long-Term Deferred Tax surged by 4251.77% in 2018 and then crashed by 9321.17% in 2022.
  • Orthofix Medical's Long-Term Deferred Tax (Quarter) stood at $33.2 million in 2018, then increased by 5.68% to $35.1 million in 2019, then decreased by 28.69% to $25.0 million in 2020, then crashed by 92.93% to $1.8 million in 2021, then fell by 12.82% to $1.5 million in 2022.
  • Its last three reported values are $1.5 million in Q3 2022, $1.5 million for Q2 2022, and $1.9 million during Q1 2022.